ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Interest Income Over TimeStrong
Percentile Rank100
5Y CAGR+92.8%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

5Y CAGR
+92.8%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
26.7x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$10.67M-
2024$0.00-
2023$0.00-
2022$0.00-100.0%
2021$800000.00+100.0%
2020$400000.00+300.0%
2019$100000.00+132.6%
2018$43000.00-